As NCCN’s first CSO, Dr. Denlinger will oversee the organization’s research program and help lead its strategic direction. She will also contribute to the NCCN Clinical Practice Guidelines in Oncology. In addition to the CSO role, Dr. Denlinger will maintain her current position as chair of the NCCN Guidelines panel for Survivorship and continue serving on the editorial board for the organization’s medical journal.
Dr. Denlinger holds several leadership positions at Philadelphia-based Fox Chase Cancer Center, including chief of gastrointestinal and medical oncology. After starting the CSO role at NCCN, she will continue seeing a limited number of patients at the cancer center.
Dr. Denlinger is the author of hundreds of clinical research articles and abstracts. She earned her medical degree at Rutgers New Jersey Medical School.
More articles on oncology:
American Cancer Society: US cancer deaths continue to decline
Cancer survivors have older hearts, CDC finds
Foundation awards $2M+ to cancer researchers
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.